Page 76 - Sohini Das

Bharat Biotech starts re-labelling old stock after shelf life extension

After receiving the order from the Central Drugs Standard Control Organisation (CDSCO), the company started lifting unused stock from hospitals to re-label the shelf life from 9 months to 12 months

Mixing Covaxin and Covishield induces four times more antibodies: Study

The Spike-protein neutralizing antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups

Third Covid-19 wave is here; 75% cases in metros Omicron: NTAGI's N K Arora

New variant in 81% of samples genome tested: Delhi health minister

Covid-19 pandemic: Expect a slow but steady start to teen vaccination

Day 1 to see a few hundred shots administered at most sites

Hospital sector could grow at 18% when Covid ends: Manipal Hospitals CEO

The Omicron situation is still evolving but the early signs are ominous, says Jose

Indian drugmakers get close to nod for Merck's Covid antiviral Molnupiravir

The significance of the Molnupiravir approval is that it could offer an affordable oral drug to treat Covid-19, and may even be effective against the Omicron variant

Action on Omicron: Step up testing to spot new variant, says govt

The health ministry also asked states to make sure testing of international passengers is done on the first and the eighth day scrupulously

Companies gear up for Omicron version of coronavirus vaccines

Zydus to keep a laboratory product ready based on the new variant

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

WHO grants much-awaited emergency use listing to Bharat Biotech's Covaxin

Move will ease international travel for those vaccinated with the jab

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals

Mixing multiple strains to get what is called a multi-variant vaccine may be a way to get better immunity, scientists feel

Efforts upped for tracing AY.4.2 Covid strain, boosting vaccination

INSACOG expanded, ASHA workers doing man to man surveys, tracking and tracing on

DRL plans to start paediatric trials of Sputnik Light vaccine soon

Booster shot with Sputnik trials may also begin

Covid cases slow down in festival season but watch out for Diwali: Experts

Vaccinations and more people having already got the disease may have lowered the count.

Power crisis brewing in China likely to hit Indian pharma companies

Delays in consignments, rising prices of key ingredients worry industry

We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD

In a Q&A, Om Manchanda says the firm is now growing organically in the Southern market, but is open to inorganic opportunities there

Covid-19 pandemic: Vaccinating children not a priority for now, say experts

They say mRNA vaccines could offer best protection for vulnerable children

On way to 1 billion doses of Covid-19 vaccines, focus on second jab

Experts say priority should be on second dose to achieve target of vaccinating entire adult population by 2021-end

Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages

Single-dose Sputnik Light shows 70% efficacy against Delta variant

RDIF says Sputnik Light can act as a booster shot for even those who have been vaccinated with other vaccines like mRNA candidates